Loading clinical trials...
Loading clinical trials...
A Phase 1 Drug-Drug Interaction Study of S-217622 With Combined Oral Contraceptives in Healthy Adult Female Participants
Conditions
Interventions
Ensitrelvir
Locations
1
United States
Early Phase Clinical Unit Los Angeles
Glendale, California, United States
Start Date
December 30, 2024
Primary Completion Date
April 3, 2025
Completion Date
April 3, 2025
Last Updated
May 4, 2025
Lead Sponsor
Shionogi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions